Compare GIL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIL | BAX |
|---|---|---|
| Founded | 1946 | 1931 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 10.2B |
| IPO Year | 1999 | 1994 |
| Metric | GIL | BAX |
|---|---|---|
| Price | $59.48 | $17.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $78.00 | $22.13 |
| AVG Volume (30 Days) | 1.6M | ★ 9.4M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 1.50% | 0.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $76.47 | $1.90 |
| Revenue Next Year | $4.88 | $2.09 |
| P/E Ratio | $23.11 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $39.28 | $17.07 |
| 52 Week High | $73.70 | $35.03 |
| Indicator | GIL | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 26.15 | 37.42 |
| Support Level | $59.09 | $17.69 |
| Resistance Level | $62.40 | $19.31 |
| Average True Range (ATR) | 1.91 | 0.72 |
| MACD | -1.23 | -0.29 |
| Stochastic Oscillator | 4.54 | 17.89 |
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. Its primary market is the sale of blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels. Brands include Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates nearly 90% of its sales in the US. Gildan is acquiring its US rival Hanesbrands to bolster its consumer and printwear operations.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.